Page 34 - GlaxoSmithKline Pharmaceuticals AR 2012
Basic HTML Version
30
Among the various projects, GSK is currently working on a project which can be adopted by the
community. We are doing a pilot study under the project named “Strengthening Immunization in
Mumbai Slums (SIMS)”. It is a collaborative pilot project of GlaxoSmithKline, with technical support
from PATH, implemented by Committed Communities Development Trust (CCDT) in coordination with
Municipal Corporation of Greater Mumbai (MCGM).
The objective of the project was to design Web based information system to review data as per the
requirement of the health post staff and make an action plan to have 100 percent coverage of children
for routine immunization.
This project covered a population of 5 lakh in 5 health post of Deonar, Pathanwadi, Appapada,
Mankhurd and Squatters colony. Through the use of this system and its MIS, coverage increased from
34% to 51% among the eligible children of 0-2 years of age.
To read about our projects – log on to -
Patient engagement:
Patient is at the heart of our business. They are the most important stakeholders. We are actively
seeking new ways of delivering healthcare and making our products more available and affordable to
people who need them, wherever they live.
In our effort to expand access to our products we have led the industry in adopting a flexible pricing
approval to pricing our medicines and vaccines based on a country’s ability to pay. This has resulted
in significant reduction in prices, representing a good outcome for the patients.
We follow national and international standards with respect to product safety and code of engaging
with customers.
On our product packaging, we provide all the information as mentioned in Cosmetic Drugs Rule 1996.
As a part of grievance redressal, customer care no. and email id are provided along with the usage
leaflet.
From a quality perspective only four cases are pending where our response is awaited. Seven consumer
cases are pending against us.
Conclude:
Our first Business Responsibility Report discloses details related to our sustainability commitments and
management approach across the dimension for fiscal 2012.
Contact:
Mr. Raju Krishnaswamy, Executive Director is responsible for implementation of the Business
Responsibility policies. His details:
DIN No.: 03043004
Tel.: +9122 24959650
Email:
The Company’s CIN No.: L24239MH1924PLC001151
